Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology

@article{Seferovic2019ClinicalPU,
  title={Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology},
  author={Petar M. Seferovic and Piotr Ponikowski and Stefan D. Anker and Johann Bauersachs and Ovidiu Chioncel and John G. F. Cleland and Rudolf A. de Boer and Heinz Drexel and Tuvia Ben Gal and Loreena Hill and Tiny Jaarsma and Ewa Anita Jankowska and Markus S. Anker and Mitja Lainscak and Basil S. Lewis and Theresa A McDonagh and Marco Metra and Davor Mili{\vc}i{\'c} and Wilfried Mullens and Massimo Francesco Piepoli and Giuseppe M C Rosano and Frank Ruschitzka and Maurizio Volterrani and Adriaan A. Voors and Gerasimos Filippatos and Andrew J. S. Coats},
  journal={European Journal of Heart Failure},
  year={2019},
  volume={21}
}
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) over the last 25 years, most recently in 2016. Given the amount of new information that has become available since then, the Heart Failure Association (HFA) of the ESC recognized the need to review and summarise recent developments in a consensus document. Here we report from the HFA workshop that was held in January 2019 in Frankfurt, Germany. This expert consensus report is neither a guideline… Expand
Consensus on improving the comprehensive care of patients with acute heart failure.
TLDR
This consensus document was drafted with the aim of updating all aspects related to AHF and to create a document that comprehensively describes the diagnosis, treatment, and management of this disease. Expand
Figures of the Heart Failure Association (HFA): Prof. Dr. Tiny Jaarsma, HFA Board Member (2018–2020), Coordinator Patient Care: Management and Delivery Committee and Co‐Chair HFA Task Force on Palliative Care
  • A. Coats
  • Medicine
  • European journal of heart failure
  • 2019
Prof. Dr. Tiny Jaarsma has been around in the Heart Failure Association (HFA) for some time and has been active in several activities in the Association and in the journals of HFA. She currently is aExpand
The summary of the 2019 year in heart failure with reduced ejection fraction
TLDR
The present article summarized the main issues regarding heart failure with reduced ejection fraction together with comment based on the HFA expert consensus. Expand
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology
TLDR
Nine patient profiles that may be relevant for treatment implementation in HF patients with a reduced ejection fraction are identified, taking into account heart rate, the presence of atrial fibrillation, symptomatic low blood pressure, estimated glomerular filtration rate or hyperkalaemia. Expand
All rise! Orthostatic hypotension in heart failure. Letter regarding the article ‘Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients’
TLDR
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. Expand
Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
TLDR
A multiparametric evaluation may contextualize a patient with HFmrEF in a more defined phenotype with a specific prognosis, and it is reasonable to consider other parameters, such as LVEF changes over time, HF aetiology, co‐morbidities, and other imaging parameters. Expand
Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.
TLDR
This expert panel, which includes heart failure specialists, geriatricians and nephrologists, proposes therapeutic management algorithms for worsening renal function for physicians in charge of outpatients with chronic heart failure and believes that this practical clinically minded management algorithm can help to optimize HFrEF treatment in routine clinical practice. Expand
Highlights in heart failure
TLDR
An update on recent advances in all aspects of HF research is given, suggesting drugs effective in HFrEF may be useful also in HF with mid‐range ejection fraction and Meta‐analyses suggest better outcomes with ferric carboxymaltose in patients with iron deficiency. Expand
Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India
TLDR
This checklist will ensure GDMT, simplify transition of care and can be used by all doctors across India, and institutions, associations, and societies should recommend this checklist for adaptability in public and private hospital. Expand
Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.
TLDR
The authors believe that this review fills the gap between the guidelines and clinical practice and provides practical recommendations to improve HF management. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 119 REFERENCES
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
TLDR
There is an urgent need to develop evidence‐based treatment algorithms to prolong life when possible and in accordance with patient preferences, increase life quality, and reduce the burden of hospitalization in this vulnerable patient population. Expand
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians and other healthcare providers inExpand
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
TLDR
The TIM-HF2 trial suggests that a structured remote patient management intervention, when used in a well defined heart failure population, could reduce the percentage of days lost due to unplanned cardiovascular hospital admissions and all-cause mortality. Expand
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
TLDR
Patients with chronic kidney disease and HF are at increased risk of hyperkalaemia and ∼50% of these patients experience two or more yearly recurrences, so RAASi therapy should be down-titrated or more often discontinued even after a single episode of elevated potassium (K+) level. Expand
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
TLDR
Recent surveys of Guidelines and Expert Consensus Documents published in peer-reviewed journals between 1985 and 1998 have shown that methodological standards were not complied with in the vast majority of cases. Expand
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
TLDR
Survival with improved functional status was better with HMII LVAD compared with OMM, and the results support HMII use in functionally limited, noninotrope-dependent HF patients with poor HRQoL. Expand
The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
TLDR
The manuscript addresses frequently encountered challenges, such as evaluation of congestion and clinical euvolaemia, assessment of diuretic response/resistance in the treatment of acute heart failure, and an approach towards stepped pharmacologic diUREtic strategies, based upon diuretics response. Expand
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
TLDR
Patients with HFrEF who were treated with less than 50% of recommended dose of ACE-inhibitors/ARBs and beta-blockers seemed to have a greater risk of death and/or heart failure hospitalization compared with patients reaching ≥100%. Expand
Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy
TLDR
Combined CMR and 99mTc-DPD are helpful imaging tools for accurate phenotyping of patients amenable to histopathological diagnosis or genetic testing, and should be considered for proper management of this population. Expand
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
TLDR
Survival on original therapy with improvement in 6-min walk distance was superior with LVAD compared with OMM at 2 years, and reduction in key adverse events beyond 1 year was observed in the LVAD group. Expand
...
1
2
3
4
5
...